NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/17/2026
Back to search
Official data from USPTO
PARTNER THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PARTNER THERAPEUTICS
ST13
US500000087982270Class
5, 42
Filing
87982270
Registration
5939060
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/18/2026
Trademark type
Word
Nice classes
5, 42
Filing date
04/30/2018
Registration date
12/17/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/18/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/16/2019
First use in commerce
09/16/2019
Drawing code
4
Owner type
03
Owner location
Lexington, MA
Examiner
SOBRAL, CHRISTINA
Current location
Historical data usage
Holders and representatives
Holders
Partner Therapeutics, Inc.
Representatives
Brian O'Donnell Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceuticals for the treatment of acute radiation syndrome
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
44 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/17/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/17/2026
E815
TEAS SECTION 8 & 15 RECEIVED
11/12/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
02/11/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
02/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/08/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/17/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/14/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/08/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
11/08/2019
EX1G
SOU EXTENSION 1 GRANTED
11/08/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/06/2019
IUAF
USE AMENDMENT FILED
10/24/2019
DRRR
DIVISIONAL REQUEST RECEIVED
10/24/2019
EXT1
SOU EXTENSION 1 FILED
10/24/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/24/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/24/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/24/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2019
PUBO
PUBLISHED FOR OPPOSITION
04/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2019
ALIE
ASSIGNED TO LIE
03/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2018
GNRT
NON-FINAL ACTION E-MAILED
08/21/2018
CNRT
NON-FINAL ACTION WRITTEN
08/21/2018
DOCK
ASSIGNED TO EXAMINER
08/21/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2018
NWAP
NEW APPLICATION ENTERED
05/03/2018
Continuous trademark protection
Get notified about every new filing that threatens PARTNER THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.